Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging
- PMID: 36588352
- PMCID: PMC10237613
- DOI: 10.4103/EUS-D-22-00208
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging
Abstract
Sclerosing cholangitis (SC) represents a spectrum of chronic progressive cholestatic diseases of the intrahepatic and/or extrahepatic biliary system characterized by patchy inflammation, fibrosis, and stricturing. Primary and secondary SC must be distinguished given the different treatment modalities, risks of malignancy, and progression to portal hypertension, cirrhosis, and hepatic failure. This review focuses on secondary SC and the pathogenic mechanisms, risk factors, clinical presentation, and novel imaging modalities that help to distinguish between these conditions. We explore the detailed use of cholangiography and ultrasound imaging techniques.
Keywords: Cholangiography; IgG4-related sclerosing cholangitis; secondary cholangitis-critically Ill patients; secondary sclerosing cholangitis; ultrasound.
Conflict of interest statement
None
Figures










Similar articles
-
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.Gut Liver. 2019 May 15;13(3):300-307. doi: 10.5009/gnl18085. Gut Liver. 2019. PMID: 30205418 Free PMC article. Review.
-
Diagnosing Biliary Strictures: Distinguishing IgG4-Related Sclerosing Cholangitis From Cholangiocarcinoma and Primary Sclerosing Cholangitis.Mayo Clin Proc Innov Qual Outcomes. 2021 Jun 10;5(3):535-541. doi: 10.1016/j.mayocpiqo.2021.03.005. eCollection 2021 Jun. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 34195545 Free PMC article. Review.
-
Localized intrahepatic IgG4-related sclerosing cholangitis (IgG4-SC) as an additional type of IgG4-SC: a systematic analysis of 12 cases.Scand J Gastroenterol. 2018 Mar;53(3):312-318. doi: 10.1080/00365521.2018.1424233. Epub 2018 Jan 9. Scand J Gastroenterol. 2018. PMID: 29313399
-
Classification and Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis.Gut Liver. 2022 Jan 15;16(1):28-36. doi: 10.5009/gnl210116. Gut Liver. 2022. PMID: 34380781 Free PMC article. Review.
-
Diagnosis of IgG4-related sclerosing cholangitis.World J Gastroenterol. 2013 Nov 21;19(43):7661-70. doi: 10.3748/wjg.v19.i43.7661. World J Gastroenterol. 2013. PMID: 24282356 Free PMC article. Review.
Cited by
-
Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.Med Rev (2021). 2024 Jul 1;4(4):326-365. doi: 10.1515/mr-2024-0029. eCollection 2024 Aug. Med Rev (2021). 2024. PMID: 39135601 Free PMC article. Review.
-
Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies.Front Immunol. 2025 Mar 28;16:1575554. doi: 10.3389/fimmu.2025.1575554. eCollection 2025. Front Immunol. 2025. PMID: 40226624 Free PMC article. Review.
References
-
- Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver –Update 2012:A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39:187–210. - PubMed
-
- Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver –Update 2012:A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34:11–29. - PubMed
-
- Dietrich CF, Nolsøe CP, Barr RG, et al. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol. 2020;46:2579–604. - PubMed
-
- Dietrich CF, Nolsøe CP, Barr RG, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver –Update 2020 –WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 2020;41:562–85. - PubMed